Evaluation of anastomotic hyperplasia progression using the cyclin specific antibody MIB-1

American Journal of Surgery

Volumn 172, Issue 2, 1996, Pages 168-171

  Hamdan, Allen D ^a,b   Misare, Bruce ^a   Contreras, Mauricio ^a   LoGerfo, Frank W ^a   Quist, William C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Div Vasc Endovascular Surg D   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY KI 67;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CELL PROLIFERATION; CONTROLLED STUDY; DOG; END TO END ANASTOMOSIS; GRAFT FAILURE; NONHUMAN; POLITEF IMPLANT; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TUNICA MEDIA;

EID: 0030218193     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(96)00143-2     Document Type: Article

References (10)

1. 1. Clowes AW. Pathologic intimal hyperplasia as a response to vascular injury and reconstruction. In: Rutherford RB, ed. Vascular Surgery. Philadelphia: WB Saunders; 1989:266-275.
2. 2. Imparato AM, Barcco A, Kim GF, Zeff R. Intimal and neointimal fibrous proliferation causing failure of arterial reconstruction. Surgery. 1972;72:1007-1017.
3. 3. LoGerfo RW, Crawshaw HM, Quist WC, et al. Downstream anastomotic hyperplasia: a mechanism of failure in dacron arterial grafts. Ann Surg. 1983;1197:479-483.
4. 4. Cantelmo NL, Quist WC, LoGerfo FW. Quantitative analysis of anastomotic intimal hyperplasia in paired Dacron and PTFE grafts. J Cardiovasc Surg. 1989;30:910-915.
5. 5. Ross R. The pathogenesis of atherosclerosis - an update. NEJM. 1986;20:488-500.
6. 6. Kubbutat MH, Key G, Duchrow M, et al. Epitope analysis of antibodies recognizing the cell proliferation associated nuclear antigen previously defined by the antibody Ki-67 (Ki-67 protein). J Clin Pathol. 1994;47(6):524-528.
7. 7. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208-215.
8. 8. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet derived growth factor. Cell. 1986;46:155-169.
9. 9. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Nat Acad Sci USA. 1991;1:3739-3743.
10. 10. Powell JS, Clozel J-P, Muller RKM, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989;245:186-188.